AmerisourceBergen exec highlights his 'state of the industry' address that he made at day one of the conference.
In an interview with Pharma Commerce Editor, Nicholas Saraceno, Corey Ford, VP of reimbursement & policy insight, AmerisourceBergen, talks state of the industry at Access PAP 2023.
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
July 2nd 2025As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose between single-brand or multi-brand approaches.